MedTrace Logo

Study of Ocular Penetration of Topically Administered Fluoroquinolones

NCT00924729 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-10-24

Study results available
· View outcomes & findings →

Summary

This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Conditions

  • Cataract Extraction

Interventions

DRUG

Moxifloxacin 0.5% ophthalmic solution

Administer moxifloxacin study drug prior to cataract surgery.

DRUG

Besifloxacin 0.6% ophthalmic suspension

Administer besifloxacin study drug prior to cataract surgery.

Sponsors & Collaborators

Principal Investigators

  • Walter J. Stark, M.D. · The Wilmer Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-10-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00924729 on ClinicalTrials.gov